Organon & Co., headquartered in Jersey City, New Jersey, is a global healthcare company dedicated to improving women's health. Founded with a mission to provide better and healthier lives for women, Organon specializes in reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. The company offers a diverse portfolio of therapies and products across various therapeutic areas including heart disease, oncology, immunology, dermatology, allergy, and asthma.
Notably, Organon emphasizes female leadership, with over 50% of its board of directors being women. The company has achieved significant market presence, deriving a third of its revenue from the United States despite producing all its products internationally. Organon's impact is profound in advancing women's health on a global scale, contributing to increased representation and focus on female-centric healthcare solutions.
